on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has released a Form 8.3 following Rule 8.3 of the Irish Takeover Panel Act, 1997. This disclosure highlights Vanguard's position concerning Mural Oncology plc. As of November 20, 2025, Vanguard holds 289,179 of Mural Oncology's $0.01 ordinary shares, accounting for 1.67% of the total securities. The form details no short positions or derivatives linked to these shares.
No dealings with other securities classes or parties related to the offer were reported. Vanguard made a small purchase of 288 ordinary shares at $2.10 each. The statement confirms no indemnities, agreements, or understandings that could influence dealings with Mural Oncology's securities. A Supplemental Form 8 is not attached to this filing.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news